GoumasG.S.Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins?Angiology.2008 Nov 18 [Epub ahead of print].
2.
HaywardR.A., HoferT.P., VijanS.Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem.Ann Intern Med.2006; 145: 520–530.
3.
BotsM.L., VisserenF.L., EvansG.W., and the RADIANCE 2 Investigators. Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.Lancet.2007; 370: 153–160.
4.
PedoneC., CarboninP., KasteleinJ.J., and the ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia.N Engl J Med.2008; 358: 1431–43 [Erratum in: N Engl J Med 2008; 358:1977].
5.
RossouwJ.E., AndersonG.L., PrenticeR.L., for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trialJAMA.2002; 288: 321–333.
6.
W.H.O.cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators.Lancet.1980; 2: 379–385.
7.
de LorgerilM., RenaudS., MamelleN.Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease.Lancet.1994; 343: 1454–1459.
8.
SacksF.M., MoyeL.A., DavisB.R.Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the cholesterol and recurrent events trial.Circulation.1998; 97: 1446–1452.
9.
VersmissenJ., OosterveerD.M., YazdanpanahM.Efficacy of statins in familial hypercholesterolaemia: a long term cohort study.EMJ.2008; 337: a2423.
10.
MascitelliL., RavnskovU., PezzettaF., GoldsteinM.R.After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.Angiology. IN PRESS.
